Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016 (2016), Article ID 9324279, 8 pages
http://dx.doi.org/10.1155/2016/9324279
Research Article

Preliminary Evaluation of Clinical and Angiographic Outcomes with Biodegradable Polymer Coated Sirolimus-Eluting Stent in De Novo Coronary Artery Disease: Results of the MANIPAL-FLEX Study

1Kasturba Medical College and Hospital, Manipal, Karnataka 576104, India
2Apollo Hospitals International Limited, Gandhinagar, Gujarat 382428, India

Received 24 December 2015; Revised 6 May 2016; Accepted 2 June 2016

Academic Editor: Klaus Kettering

Copyright © 2016 Ranjan Shetty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Daemen, P. Wenaweser, K. Tsuchida et al., “Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study,” The Lancet, vol. 369, no. 9562, pp. 667–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kimura, T. Morimoto, Y. Nakagawa et al., “Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-cypher registry,” Circulation, vol. 125, no. 4, pp. 584–591, 2012. View at Publisher · View at Google Scholar
  3. R. A. Byrne, A. Kastrati, K. Tiroch et al., “2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based cypher and endeavor, drug-eluting stents,” Journal of the American College of Cardiology, vol. 55, no. 23, pp. 2536–2543, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Nebeker, R. Virmani, C. L. Bennett et al., “Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project,” Journal of the American College of Cardiology, vol. 47, no. 1, pp. 175–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-J. Park, S.-J. Kang, R. Virmani, M. Nakano, and Y. Ueda, “In-stent neoatherosclerosis: a final common pathway of late stent failure,” Journal of the American College of Cardiology, vol. 59, no. 23, pp. 2051–2057, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Nordmann, M. Briel, and H. C. Bucher, “Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis,” European Heart Journal, vol. 27, no. 23, pp. 2784–2814, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Joner, A. V. Finn, A. Farb et al., “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 193–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. H. Hofma, W. J. Van Der Giessen, B. M. Van Dalen et al., “Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation,” European Heart Journal, vol. 27, no. 2, pp. 166–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kolandaivelu, R. Swaminathan, W. J. Gibson et al., “Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings,” Circulation, vol. 123, no. 13, pp. 1400–1409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Briguori, C. Sarais, P. Pagnotta et al., “In-stent restenosis in small coronary arteries: impact of strut thickness,” Journal of the American College of Cardiology, vol. 40, no. 3, pp. 403–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Jabara, S. Geva, H. B. Ribeiro et al., “A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries,” EuroIntervention, vol. 5, no. 5, pp. 619–626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Kereiakes, D. A. Cox, J. B. Hermiller et al., “Usefulness of a cobalt chromium coronary stent alloy,” American Journal of Cardiology, vol. 92, no. 4, pp. 463–466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Martin and F. J. Boyle, “Drug-eluting stents for coronary artery disease: a review,” Medical Engineering and Physics, vol. 33, no. 2, pp. 148–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. E. A. Sprague, M. L. Pomeranz, I. Odess, S. M. Furnish, and J. F. Granada, “Surface material, surface treatment and nanotechnology in cardiovascular stent development,” EuroIntervention, vol. 4, pp. C60–C62, 2008. View at Google Scholar · View at Scopus
  15. C. D. Rogers, “Optimal stent design for drug delivery,” Reviews in Cardiovascular Medicine, vol. 5, supplement, pp. S9–S15, 2004. View at Google Scholar
  16. A. Kastrati, J. Mehilli, J. Dirschinger et al., “Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (isar-stereo) trial,” Circulation, vol. 103, no. 23, pp. 2816–2821, 2001. View at Publisher · View at Google Scholar
  17. S. B. King III, S. C. Smith Jr., J. W. Hirshfeld Jr. et al., “2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 Writing Committee,” Circulation, vol. 117, no. 2, pp. 261–295, 2008. View at Google Scholar
  18. D. E. Cutlip, S. Windecker, R. Mehran et al., “Clinical end points in coronary stent trials: a case for standardized definitions,” Circulation, vol. 115, no. 17, pp. 2344–2351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Virmani, G. Guagliumi, A. Farb et al., “Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?” Circulation, vol. 109, no. 6, pp. 701–705, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kahn, “TCT Daily: ESTROFA: late thrombosis not increased in DES patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors,” Journal of interventional cardiology, vol. 20, no. 1, p. 32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Buszman, S. Trznadel, K. Milewski et al., “Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry,” Catheterization and Cardiovascular Interventions, vol. 71, no. 1, pp. 51–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. G. Stefanini, B. Kalesan, P. W. Serruys et al., “Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial,” The Lancet, vol. 378, no. 9807, pp. 1940–1948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Wykrzykowska, P. Serruys, P. Buszman et al., “The three year follow-up of the randomised ‘all-comers’ trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (Leaders),” EuroIntervention, vol. 7, no. 7, pp. 789–795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. M. Beijk and J. J. Piek, “XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent,” Expert Review of Medical Devices, vol. 4, no. 1, pp. 11–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Moliterno, “Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents,” Catheterization and Cardiovascular Interventions, vol. 69, no. 6, pp. 799–800, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. H. Sketch Jr., M. Ball, B. Rutherford, J. J. Popma, C. Russell, and D. J. Kereiakes, “Evaluation of the medtronic (Driver) cobalt-chromium alloy coronary stent system,” American Journal of Cardiology, vol. 95, no. 1, pp. 8–12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Legrand, H. Kelbaek, K. E. Hauptmann et al., “Clinical and angiographic analysis with a Cobalt Alloy Coronary Stent (Driver) in stable and unstable angina pectoris,” American Journal of Cardiology, vol. 97, no. 3, pp. 349–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Seth, P. Chandra, N. S. Chouhan, and A. S. Thakkar, “A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients,” Indian Heart Journal, vol. 64, no. 6, pp. 547–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. S. Thakkar, A. D. Abhyankar, S. I. Dani et al., “Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study,” Indian Heart Journal, vol. 64, no. 3, pp. 273–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. D. Abhyankar and A. S. Thakkar, “In vivo assessment of stent recoil of biodegradable polymer-coated cobalt-chromium sirolimus-eluting coronary stent system,” Indian Heart Journal, vol. 64, no. 6, pp. 541–546, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. D. Abhyankar, J. Prajapati, and S. Reddy, “Early vascular healing with biodegradable polymer coated sirolimus-eluting coronary stent implantation: assessed by optical coherence tomography results at 4-month follow-up,” Minerva Cardioangiologica, vol. 61, no. 3, pp. 313–322, 2013. View at Google Scholar · View at Scopus
  32. P. Chandwani, A. D. Abhyankar, J. S. Prajapati, S. C. Porwal, and A. S. Thakkar, “Clinical performance of the cobalt-chromium biodegradable polymer coated sirolimus-eluting stent in an unselected real-world population,” International Journal of Clinical Medicine, vol. 5, pp. 206–215, 2014. View at Publisher · View at Google Scholar
  33. P. Chandwani, J. Prajapati, S. Porwal, B. Khambhati, and A. Thakkar, “Evaluation of clinical outcomes in patients undergoing dual vessel percutaneous coronary intervention using sirolimus-eluting coronary stent system in India,” Journal of Clinical and Diagnostic Research, vol. 9, no. 2, pp. OC05–OC09, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Banker, A. Ahuja, H. Sanadhya et al., “Clinical performance of biodegradable polymer-coated sirolimus-eluting stents in unselected real-world population with coronary artery disease: results from the multicenter CORE Registry,” Minerva Cardioangiologica, vol. 64, no. 1, pp. 9–14, 2016. View at Google Scholar
  35. S. J. Pocock, A. J. Lansky, R. Mehran et al., “Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials,” Journal of the American College of Cardiology, vol. 51, no. 1, pp. 23–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Chevalier, S. Silber, S. J. Park et al., “Randomized comparison of the nobori biolimus a9-eluting coronary stent with the taxus liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the nobori 1 trial—phase 2,” Circulation: Cardiovascular Interventions, vol. 2, no. 3, pp. 188–195, 2009. View at Google Scholar
  37. P. W. Serruys, A. T. Ong, J. J. Piek et al., “A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the spirit first trial,” EuroIntervention, vol. 1, no. 1, pp. 58–65, 2005. View at Google Scholar
  38. R. A. Costa, A. J. Lansky, A. Abizaid et al., “Angiographic results of the first human experience with the biolimus A9 drug-eluting stent for de novo coronary lesions,” American Journal of Cardiology, vol. 98, no. 4, pp. 443–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. I. T. Meredith, S. Verheye, N. J. Weissman et al., “Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent,” EuroIntervention, vol. 9, no. 3, pp. 308–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Barbato, S. Salinger-Martinovic, D. Sagic et al., “A first-in-man clinical evaluation of Ultimaster, a new drugeluting coronary stent system: Century study,” EuroIntervention, vol. 11, no. 5, pp. 541–548, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Waltenberger, J. Brachmann, J. van der Heyden et al., “Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry,” EuroIntervention, vol. 11, no. 10, pp. 1106–1110, 2016. View at Publisher · View at Google Scholar
  42. R. Shetty, U. Pai, K. Shetty, B. Khambhati, and A. Thakkar, “Evaluation of clinical and angiographic outcomes with bioabsorbable polymer coated sirolimus-eluting stent in de novo coronary artery disease: results of the MANIPAL-FLEX first-in-man study,” EuroIntervention, 2015. View at Google Scholar